WallStreetZenWallStreetZen

NASDAQ: KPTI
Karyopharm Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Karyopharm Therapeutics earnings were -$62.5M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest KPTI earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$23.5M, down 23.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, KPTI reported annual earnings of -$76.4M, with -46.6% growth.

KPTI earnings history

Current Revenue
$142.1M
Current Earnings
-$62.5M
Current Profit Margin
-44%

KPTI Return on Equity

Insufficient data to display

KPTI undefined

Current Company
-36%
Current Industry
-2.1%
KPTI is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when KPTI announces earnings.

KPTI undefined

Current Company
-53.47%
Current Industry
6.4%
KPTI's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

KPTI vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
KPTI-$19.64M-$62.52MN/A-$8.17
OSTX-$10.07M-$13.27MN/A-$0.86
MURA-$127.22M-$130.73MN/A-$7.67
CAMPN/AN/AN/AN/A
IRD-$57.52M-$57.53MN/A-$2.15
View Top Biotech Stocks

Karyopharm Therapeutics Earnings Reports & History FAQ

What were Karyopharm Therapeutics's earnings last quarter?

On KPTI's earnings call on Invalid Date, Karyopharm Therapeutics (NASDAQ: KPTI) reported Q1 2025 earnings per share (EPS) of -$2.77, up 42.89% year over year. Total KPTI earnings for the quarter were -$23.46 million. In the same quarter last year, Karyopharm Therapeutics's earnings per share (EPS) was -$4.85.

If you're new to stock investing, here's how to buy Karyopharm Therapeutics stock.

Is Karyopharm Therapeutics profitable or losing money?

As of the last Karyopharm Therapeutics earnings report, Karyopharm Therapeutics is currently losing money. Karyopharm Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$62.52 million, a 57.27% decrease year over year.

What was KPTI's earnings growth in the past year?

As of Karyopharm Therapeutics's earnings date in Invalid Date, Karyopharm Therapeutics's earnings has grown year over year. KPTI earnings in the past year totalled -$62.52 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.